Response to FOLFIRINOX by gender in patients with metastatic pancreatic cancer: Results from the PRODIGE 4/ ACCORD 11 randomized trial
ANNÉE
2017
AUTEURS
Lambert A, Jarlier M, Gourgou Bourgade S, Conroy T
CONGRÈS/REVUE
PLoS One
ÉTUDE
Localisation
LIEN PUBLICATIONS ASSOCIÉES